Therefore, to investigate the mechanisms by which RAD21 and CSE1L affect the efficacy of immunotherapy, we examined the correlations between various immune suppressive factors and RAD21/CSE1L in 14 ovarian cancer datasets (Figure 4J). The gene discussed is CSE1L; the disease is ovarian cancer.